9/11 Firefighters at Greater Risk of Multiple Myeloma Precursor, Study Reports
New York City firefighters exposed to the 9/11 World Trade Center (WTC) disaster are at greater risk for developing a condition called monoclonal gammopathy of…
News
Stand Up to Cancer Awards $10 Million to ‘Dream Team’ Focused on Early Detection of Precursor Multiple Myeloma Conditions
Stand Up to Cancer (SU2C) recently awarded $10 million to a SU2C Dream Team that wants to move the treatment of multiple myeloma from…
Chip-based Blood Test Might Replace Bone Marrow Biopsies for Myeloma, Scientists Say
Researchers say they have developed a low-cost, reliable, chip-based blood test to detect multiple myeloma, which could replace the painful bone marrow biopsy. Their…
Phase 1 Trial for Investigational Therapy STRO-001 Treats First Myeloma, Lymphoma Patients
A Phase 1 clinical trial testing therapy candidate STRO-001 for lymphoma and myeloma has started treating its first patients, announced Sutro Biopharma, the therapy’s…
New Method of Classifying Malignant Myeloma Cells Improves Outcomes, Study Finds
A new method that selects and isolates malignant myeloma cells based on their size and molecular markers enables more precise detection of chromosomal abnormalities, University…
P-BCMA-101 Shows Early Effectiveness in First Multiple Myeloma Patients Treated in Phase 1 Trial
P-BCMA-101, Poseida Therapeutics’ CAR T-cell therapy, is safe and effective in relapsed or refractory multiple myeloma patients, results from the first three patients enrolled…
Seattle Genetics’ Investigational Therapy Fares Well in Multiple Myeloma Animal Models
A new antibody targeting the BCMA protein — called SEA-BCMA — has shown promising effectiveness and safety results in animal models of multiple myeloma, making…
Screening for Multiple Myeloma Precursor Could Cut Deaths from the Cancer, Study Finds
Screening people with a family history of a multiple myeloma precursor would significantly reduce the chance that a person would develop and die of the cancer, a…
Selinexor Gains FDA Fast Track Designation for Refractory Multiple Myeloma Patients
Selinexor, the lead oral therapy developed by Karyopharm Therapeutics, received …
China FDA Prepares to Review Evomela for Approval in Multiple Myeloma Treatment
Multiple myeloma patients in China may soon have access to an injectable formulation of melphalan, called Evomela, as the China Food and Drug…
